Treatment of postmenopausal osteoporosis with recombinant human parathyroid hormone and electromagnetic field
The combination of EMF and rhPTH can significantly improve the bone turnover and BMD of PMOP patients, and may serve as a clinical treatment of PMOP.
Authors
- Zhuangli Xie
- Wei Bi (ORCID: https://orcid.org/0000-0003-3472-8801)
- Bo Wang (ORCID: https://orcid.org/0000-0003-1029-3954)
- Ying Li (ORCID: https://orcid.org/0000-0003-3683-9695)
- Qi Liu (ORCID: https://orcid.org/0000-0002-6599-649X)
- Lige Song
- Miao Xuan
- Xiuzhen Zhang (ORCID: https://orcid.org/0000-0003-3065-039X)
Institutions
- Tongji University (CN)
- Tongji Hospital (CN)
- Yangpu Hospital of Tongji University (CN)
Publication Details
- Journal
- Aging Clinical and Experimental Research
- Published
- 2025-02-22
- DOI
- https://doi.org/10.1007/s40520-025-02932-w
- Citations
- 2
- Primary Topic
- Bone health and osteoporosis research
- Type
- article
- Field-Weighted Citation Impact
- 3.44
Funders
- Tongji University